We are investigating Tavneos legal cases for people who have developed the Tavneos side-effects of vanishing bile duct syndrome (VBDS) or drug-induced liver injury (DILI). In this post, we share some case criteria and drug injury law information, presenting factors relevant to a possible “new” Tavneos litigation involving personal injury and wrongful death claims.

Tavneos Legal Cases

As of this point in time, Tavneos legal cases alleging drug injury could be filed for a person diagnosed with vanishing bile duct syndrome (VBDS) or drug-induced liver injury (DILI). These are the two types of established Tavneos side-effects outlined in this March 2026 Drug Safety Communication, “FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan) for Severe Active Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated Vasculitis“.

As regards vanishing bile duct syndrome (VBDS), a rather distinctive and singular medical condition, from that FDA Tavneos warning:

Some cases involved vanishing bile duct syndrome (VBDS), which is characterized by progressive destruction and disappearance of the bile ducts in the liver. This condition can slow or stop the flow of bile and may lead to permanent liver damage. VBDS is often accompanied by the yellowing of skin or eyes (jaundice), itchiness, and tiredness.

To provide some facts and guidance about a possible Tavenos-related drug-induced liver injury (DILI) — because that “umbrella” term touches upon various types of liver disease and therefore, is a more complex topic — we refer you to this “Drug-induced liver injury” page of the online Medical Encyclopedia on the MedlinePlus website, published by the US NIH National Library of Medicine.

Those Tavneos lawsuits will seek legal compensation from the responsible drug companies through a Complaint filed in a federal or state court as a drug injury lawsuit.

Drug Injury Law Information

The Complaint in a drug injury lawsuit for Tavenos-related liver damage, such as vanishing bile duct syndrome (VBDS) or drug-induced liver injury (DILI), would likely begin with setting the factual stage generally, then moving on to a set of standard liability allegations and contentions.

We provide the following five (5) points of drug injury law information in an attempt to give you some idea about what types of statements, typically, might be included in Tavneos legal cases with personal injury and wrongful death claims:

1. It is not unusual for an FDA-approved drug that appeared effective and safe to later be found to be unsafe. One reason is that after a drug comes onto the market and is prescribed to a larger patient population, harmful patterns can emerge that were not fully understood during the smaller “pre-approval” clinical trials.
2. If a drug is later found to be unsafe, it is possible that the particular drug side effect was not adequately disclosed, not adequately investigated, or not properly acted upon once drug-safety “signals”, or warning signs, emerged.
3. In that setting, Tavneos legal cases may focus on whether drug label safety warnings were timely and strong enough, whether physician communications such as “Dear Doctor letters’ should have been issued, and whether the responsible drug companies gave enough weight to the liver injury drug-safety “signals”, or warning signs, that emerged since the FDA first approved Tavneos in October 2021.
4. Moreover, the fact that there has been a “disagreement” between the FDA and the drug companies may be a factor in Tavneos legal cases. It could be expected that, where the FDA expressed concern that Tavneos liver injury side effects are serious enough to seek removal of Tavneos from the US market, the plaintiffs in these Tavneos legal cases may argue that the drug companies should have disclosed, investigated, or acted sooner to protect patients. (For details on this “disagreement”, see the last part of our 3/31/26 post, “Tavneos Liver Injury Drug Safety Communication Issued by FDA in Late March 2026 — Just 2 Months Earlier, Amgen Refused an FDA Request to Withdraw Tavneos; Will There Be a Tavneos Recall Soon?”)
5. For the reasons above, injured patients may pursue legal compensation by means of drug injury lawsuits, which often focus on inadequate or missing safety warnings, delayed action or investigation in connection with drug-safety “signals”, and other conduct that shows a failure to fully protect patients from emerging or known serious side effects risks.

For people with possible Tavneos legal cases, you can submit a Drug Injury Case Evaluation Form online. It is free, confidential, and there is no obligation. You will get a reply from drug injury lawyer Tom Lamb no later than the next business day.

In the alternative and/or for more relevant drug injury law information, send an email to Tom Lamb at TJL@LambLawOffice.com, or call him at 910-256-2971.

Tavneos

Free Case Evaluation

Strictly Confidential, No Obligation